CURIS, INC. Share-based Payment Arrangement, Expense
CURIS, INC. (CRIS) reported Share-based Payment Arrangement, Expense of $569.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-14
- CURIS, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $569.00K, a 49.87% decline year-over-year.
- CURIS, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $575.00K, a 50.60% decline year-over-year.
- CURIS, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was -$3.22B, a 251582.97% decline year-over-year.
- CURIS, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $924.00K, a 33.24% decline year-over-year.
- CURIS, INC. share-based payment arrangement, expense for fiscal 2025 was $4.02M, a 32.21% decline from fiscal 2024.
- CURIS, INC. share-based payment arrangement, expense for fiscal 2024 was $5.93M, a 1.22% decline from fiscal 2023.
- CURIS, INC. share-based payment arrangement, expense for fiscal 2023 was $6.00M, a 11.14% decline from fiscal 2022.
- CURIS, INC. share-based payment arrangement, expense for fiscal 2022 was $6.75M, a 27.90% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $569.00K 10-Q · filed 2026-08-14 | $1.14B 10-Q · filed 2026-08-14 | -$3.22B derived: sum of 3 quarters · filed 2026-08-14 | -$3.22B derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $575.00K 10-Q · filed 2026-05-13 | -$3.22B derived: sum of 2 quarters · filed 2026-05-13 | -$3.22B derived: sum of 3 quarters · filed 2026-05-13 | -$3.22B derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$3.22B derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$3.22B derived: sum of 2 quarters · filed 2026-03-24 | -$3.22B derived: sum of 3 quarters · filed 2026-08-14 | $4.02M 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | $924.00K 10-Q · filed 2025-11-06 | $2.06M derived: sum of 2 quarters · filed 2026-08-14 | $3.22B 10-Q · filed 2025-11-06 | $4.50M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $1.14M 10-Q · filed 2026-08-14 | $2.30M 10-Q · filed 2026-08-14 | $2.30B 10-Q · filed 2025-08-05 | $3.58M derived: sum of 3 quarters · filed 2026-08-14 | $4.96M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $1.16M 10-Q · filed 2026-05-13 | $2.44M derived: sum of 2 quarters · filed 2026-05-13 | $3.83M derived: sum of 3 quarters · filed 2026-05-13 | $5.53M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $2.66M derived: sum of 2 quarters · filed 2026-03-24 | $4.37M derived: sum of 3 quarters · filed 2026-03-24 | $5.93M 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | $1.38M 10-Q · filed 2025-11-06 | $3.09M derived: sum of 2 quarters · filed 2025-11-06 | $4.65M 10-Q · filed 2025-11-06 | $4.65B 10-Q · filed 2024-11-14 | $6.20M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | $1.70M 10-Q · filed 2025-08-05 | $3.26M 10-Q · filed 2025-08-05 | $3.26B 10-Q · filed 2024-08-01 | $4.81M derived: sum of 3 quarters · filed 2025-08-05 | $6.44M derived: sum of 4 quarters · filed 2025-08-05 | |||
| 2024-03-31 | $1.56M 10-Q · filed 2025-05-06 | $3.11M derived: sum of 2 quarters · filed 2025-05-06 | $4.74M derived: sum of 3 quarters · filed 2025-05-06 | $6.16M derived: sum of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.18M derived: sum of 2 quarters · filed 2025-03-31 | $4.61M derived: sum of 3 quarters · filed 2025-03-31 | $6.00M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $1.63M 10-Q · filed 2024-11-14 | $1.63B 10-Q · filed 2023-11-02 | $3.06M derived: sum of 2 quarters · filed 2024-11-14 | $4.45M 10-Q · filed 2024-11-14 | $4.45B 10-Q · filed 2023-11-02 | $6.20M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $1.42M 10-Q · filed 2024-08-01 | $1.42B 10-Q · filed 2023-08-03 | $2.82M 10-Q · filed 2024-08-01 | $2.82B 10-Q · filed 2023-08-03 | $4.56M derived: sum of 3 quarters · filed 2024-08-01 | $5.89M derived: sum of 4 quarters · filed 2024-08-01 | ||
| 2023-03-31 | $1.40M 10-Q · filed 2024-05-07 | $1.40B 10-Q · filed 2023-05-04 | $3.14M derived: sum of 2 quarters · filed 2024-05-07 | $4.46M derived: sum of 3 quarters · filed 2024-05-07 | $6.43M derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $3.07M derived: sum of 2 quarters · filed 2024-02-08 | $5.03M derived: sum of 3 quarters · filed 2024-02-08 | $6.75M 10-K · filed 2024-02-08 | ||||
| 2022-09-30 | $1.32M 10-Q · filed 2023-11-02 | $1.32B 10-Q · filed 2022-11-09 | $3.29M derived: sum of 2 quarters · filed 2023-11-02 | $5.01M 10-Q · filed 2023-11-02 | $5.01B 10-Q · filed 2022-11-09 | $6.45M derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | $1.97M 10-Q · filed 2023-08-03 | $1.97B 10-Q · filed 2022-08-04 | $3.68M 10-Q · filed 2023-08-03 | $3.68B 10-Q · filed 2022-08-04 | $5.13M derived: sum of 3 quarters · filed 2023-08-03 | $6.59M derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | $1.72M 10-Q · filed 2023-05-04 | $1.72B 10-Q · filed 2022-05-05 | $3.16M derived: sum of 2 quarters · filed 2023-05-04 | $4.62M derived: sum of 3 quarters · filed 2023-05-04 | $5.90M derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $2.90M derived: sum of 2 quarters · filed 2023-03-13 | $4.18M derived: sum of 3 quarters · filed 2023-03-13 | $5.28M 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | $1.46M 10-Q · filed 2022-11-09 | $1.46B 10-Q · filed 2021-11-09 | $2.74M derived: sum of 2 quarters · filed 2022-11-09 | $3.84M 10-Q · filed 2022-11-09 | $3.84B 10-Q · filed 2021-11-09 | $4.70M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $1.27M 10-Q · filed 2022-08-04 | $1.27B 10-Q · filed 2021-08-03 | $2.37M 10-Q · filed 2022-08-04 | $2.37B 10-Q · filed 2021-08-03 | $3.24M derived: sum of 3 quarters · filed 2022-08-04 | $3.86M derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $1.10M 10-Q · filed 2022-05-05 | $1.96M derived: sum of 2 quarters · filed 2022-05-05 | $2.59M derived: sum of 3 quarters · filed 2022-05-05 | $3.17M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $865.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.49M derived: sum of 2 quarters · filed 2022-02-24 | $2.07M derived: sum of 3 quarters · filed 2022-02-24 | $2.70M 10-K · filed 2022-02-24 | ||||
| 2020-09-30 | $624.00K 10-Q · filed 2021-11-09 | $1.21M derived: sum of 2 quarters · filed 2021-11-09 | $1.83M 10-Q · filed 2021-11-09 | $2.53M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $585.00K 10-Q · filed 2021-08-03 | $1.21M 10-Q · filed 2021-08-03 | $1.90M derived: sum of 3 quarters · filed 2022-02-24 | $2.59M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $625.00K 10-Q · filed 2021-05-12 | $1.32M derived: sum of 2 quarters · filed 2022-02-24 | $2.00M derived: sum of 3 quarters · filed 2022-02-24 | $2.63M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $692.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.38M derived: sum of 2 quarters · filed 2022-02-24 | $2.01M derived: sum of 3 quarters · filed 2022-02-24 | $2.66M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $684.00K 10-Q · filed 2020-11-10 | $1.31M derived: sum of 2 quarters · filed 2020-11-10 | $1.97M 10-Q · filed 2020-11-10 | $2.60M derived: sum of 4 quarters · filed 2020-11-10 | ||||
| 2019-06-30 | $631.00K 10-Q · filed 2020-08-04 | $1.28M 10-Q · filed 2020-08-04 | $1.91M derived: sum of 3 quarters · filed 2020-08-04 | $2.81M derived: sum of 4 quarters · filed 2020-08-04 | ||||
| 2019-03-31 | $651.00K 10-Q · filed 2020-05-12 | $1.28M derived: sum of 2 quarters · filed 2020-05-12 | $2.18M derived: sum of 3 quarters · filed 2020-05-12 | $3.37M derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | $631.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $1.53M derived: sum of 2 quarters · filed 2020-03-19 | $2.71M derived: sum of 3 quarters · filed 2020-03-19 | $3.94M 10-K · filed 2020-03-19 | ||||
| 2018-09-30 | $895.00K 10-Q · filed 2019-11-05 | $2.08M derived: sum of 2 quarters · filed 2019-11-05 | $3.31M 10-Q · filed 2019-11-05 | $4.69M derived: sum of 4 quarters · filed 2019-11-05 | ||||
| 2018-06-30 | $1.19M 10-Q · filed 2019-08-09 | $2.42M 10-Q · filed 2019-08-09 | $3.79M derived: sum of 3 quarters · filed 2019-08-09 | $5.09M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $1.23M 10-Q · filed 2019-05-14 | $2.60M derived: sum of 2 quarters · filed 2019-05-14 | $3.90M derived: sum of 3 quarters · filed 2019-05-14 | $5.48M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $2.67M derived: sum of 2 quarters · filed 2019-03-26 | $4.26M derived: sum of 3 quarters · filed 2019-03-26 | $5.36M 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | $1.29M 10-Q · filed 2018-11-01 | $2.88M derived: sum of 2 quarters · filed 2018-11-01 | $3.98M 10-Q · filed 2018-11-01 | |||||
| 2017-06-30 | $1.58M 10-Q · filed 2018-08-02 | $2.69M 10-Q · filed 2018-08-02 | ||||||
| 2016-12-31 | $4.33M 10-K · filed 2018-03-08 | |||||||
| 2015-12-31 | $3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $3.63M derived: sum of 2 quarters · filed 2018-03-08 | $3.75M derived: sum of 3 quarters · filed 2018-03-08 | $3.88M 10-K · filed 2018-03-08 | $396.80K 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $106.68K 10-Q · filed 2015-11-09 | $227.50K derived: sum of 2 quarters · filed 2015-11-09 | $348.33K 10-Q · filed 2015-11-09 | $466.62K derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2015-06-30 | $120.83K 10-Q · filed 2015-08-06 | $241.66K 10-Q · filed 2015-08-06 | $359.94K derived: sum of 3 quarters · filed 2016-02-29 | $478.22K derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2015-03-31 | $120.83K 10-Q · filed 2015-05-07 | $239.11K derived: sum of 2 quarters · filed 2016-02-29 | $357.40K derived: sum of 3 quarters · filed 2016-02-29 | $465.76K derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-12-31 | $118.28K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $236.57K derived: sum of 2 quarters · filed 2016-02-29 | $344.93K derived: sum of 3 quarters · filed 2016-02-29 | $392.94K 10-K · filed 2016-02-29 | ||||
| 2014-09-30 | $118.28K 10-Q · filed 2015-11-09 | $274.66K 10-Q · filed 2014-11-10 | $226.65K derived: sum of 2 quarters · filed 2015-11-09 | $274.66K 10-Q · filed 2015-11-09 | $118.28K 10-Q · filed 2014-11-10 | |||
| 2014-06-30 | $108.37K 10-Q · filed 2015-08-06 | $156.38K 10-Q · filed 2015-08-06 | ||||||
| 2014-03-31 | $48.01K 10-Q · filed 2015-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |